Fibrinogen reduction and motor function improvement by hematopoietic growth factor treatment in chronic stroke in aged mice: A treatment frequency study

Cell Transplantation

Volumn 25, Issue 4, 2016, Pages 729-734

  Liu, Yanying ^a   Popescu, Maria ^a,b   Longo, Sharon ^a   Gao, Mei ^a   Wang, Dongliang ^b   McGillis, Sandra ^a   Zhao, Li Ru ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

Chronic stroke; Fibrinogen; Granulocyte colony stimulating factor (G CSF); Hematopoietic growth factor; Stem cell factor (SCF); Stroke recovery

Indexed keywords

FIBRINOGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT STEM CELL FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR; STEM CELL FACTOR;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; CONTROLLED STUDY; FIBRINOGEN BLOOD LEVEL; MALE; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; AGING; ANIMAL; DISEASE MODEL; DRUG EFFECTS; METABOLISM; MOTOR ACTIVITY; PATHOLOGY; PATHOPHYSIOLOGY; STROKE;

AGING; ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; FIBRINOGEN; GRANULOCYTE COLONY-STIMULATING FACTOR; MICE; MOTOR ACTIVITY; STEM CELL FACTOR; STROKE;

EID: 84962439768     PISSN: 09636897     EISSN: 15553892     Source Type: Journal    
DOI: 10.3727/096368916X690791     Document Type: Article

References (31)

1. Ahn, H. J.; Glickman, J. F.; Poon, K. L.; Zamolodchikov, D.; Jno-Charles, O. C.; Norris, E. H.; Strickland, S. A novel Abeta-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer's disease mice. J. Exp. Med. 211(6):1049-1062; 2014.
2. Attems, J.; Jellinger, K.; Thal, D. R.; Van Nostrand, W. Review: Sporadic cerebral amyloid angiopathy. Neuropathol. Appl. Neurobiol. 37(1):75-93; 2011.
3. Beg, M.; Nizami, A.; Singhal, K. C.; Mohammed, J.; Gupta, A.; Azfar, S. F. Role of serum fibrinogen in patients of ischemic cerebrovascular disease. Nepal Med. Coll. J. 9(2):88-92; 2007.
4. Bembde, A. S. A study of plasma fibrinogen level in type-2 diabetes mellitus and its relation to glycemic control. Indian J. Hematol. Blood Transfus. 28(2):105-108; 2012.
5. Charidimou, A.; Gang, Q.; Werring, D. J. Sporadic cerebral amyloid angiopathy revisited: Recent insights into pathophysiology and clinical spectrum. J. Neurol. Neurosurg. Psychiatry 83(2):124-137; 2012.
6. Cortes-Canteli, M.; Paul, J.; Norris, E. H.; Bronstein, R.; Ahn, H. J.; Zamolodchikov, D.; Bhuvanendran, S.; Fenz, K. M.; Strickland, S. Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: A possible contributing factor to Alzheimer's disease. Neuron 66(5):695-709; 2010.
7. Cortes-Canteli, M.; Strickland, S. Fibrinogen, a possible key player in Alzheimer's disease. J. Thromb. Haemost. 7(Suppl. 1):146-150; 2009.
8. Cui, L.; Duchamp, N. S.; Boston, D. J.; Ren, X.; Zhang, X.; Hu, H.; Zhao, L. R. NF-kappaB is involved in brain repair by stem cell factor and granulocyte-colony stimulating factor in chronic stroke. Exp. Neurol. 263:17-27; 2015.
9. Cui, L.; Murikinati, S. R.; Wang, D.; Zhang, X.; Duan, W. M.; Zhao, L. R. Reestablishing neuronal networks in the aged brain by stem cell factor and granulocyte-colony stimulating factor in a mouse model of chronic stroke. PLoS One 8(6):e64684; 2013.
10. Duarte, R. F.; Franf, D. A. The synergy between stem cell factor (SCF) and granulocyte colony-stimulating factor (G-CSF): Molecular basis and clinical relevance. Leuk. Lymphoma 43(6):1179-1187; 2002.
11. Fu, A.; Nair, K. S. Age effect on fibrinogen and albumin synthesis in humans. Am. J. Physiol. 275(6 Pt 1):E1023-1030; 1998.
12. Klohs, J.; Baltes, C.; Princz-Kranz, F.; Ratering, D.; Nitsch, R. M.; Knuesel, I.; Rudin, M. Contrast-enhanced magnetic resonance microangiography reveals remodeling of the cerebral microvasculature in transgenic ArcAbeta mice. J. Neurosci. 32(5):1705-1713; 2012.
13. Kofoed, S. C.; Wittrup, H. H.; Sillesen, H.; Nordestgaard, B. G. Fibrinogen predicts ischaemic stroke and advanced atherosclerosis but not echolucent, rupture-prone carotid plaques: The Copenhagen City Heart Study. Eur. Heart J. 24(6):567-576; 2003.
14. Lammie, A.; Drobnjak, M.; Gerald, W.; Saad, A.; Cote, R.; Cordon-Cardo, C. Expression of c-kit and kit ligand proteins in normal human tissues. J. Histochem. Cytochem. 42(11):1417-1425; 1994.
15. Liu, X. Y.; Gonzalez-Toledo, M. E.; Fagan, A.; Duan, W. M.; Liu, Y.; Zhang, S.; Li, B.; Piao, C. S.; Nelson, L.; Zhao, L. R. Stem cell factor and granulocyte colony-stimulating factor exhibit therapeutic effects in a mouse model of CADASIL. Neurobiol. Dis. 73:189-203; 2015.
16. Lowe, G. D. Fibrinogen assays for cardiovascular risk assessment. Clin. Chem. 56(5):693-695; 2010.
17. Morimoto, A.; Sakata, Y.; Watanabe, T.; Murakami, N. Leucocytosis induced in rabbits by intravenous or central injection of granulocyte colony stimulating factor. J. Physiol. 426:117-126; 1990.
18. Muradashvili, N.; Khundmiri, S. J.; Tyagi, R.; Gartung, A.; Dean, W. L.; Lee, M. J.; Lominadze, D. Sphingolipids affect fibrinogen-induced caveolar transcytosis and cerebrovascular permeability. Am. J. Physiol. Cell Physiol. 307(2):C169-179; 2014.
19. Noguchi, J.; Nagaoka, A.; Watanabe, S.; Ellis-Davies, G. C.; Kitamura, K.; Kano, M.; Matsuzaki, M.; Kasai, H. In vivo two-photon uncaging of glutamate revealing the structure-function relationships of dendritic spines in the neocortex of adult mice. J. Physiol. 589(Pt 10):2447-2457; 2011.
20. Paul, J.; Strickland, S.; Melchor, J. P. Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease. J. Exp. Med. 204(8):1999-2008; 2007.
21. Piao, C. S.; Gonzalez-Toledo, M. E.; Xue, Y. Q.; Duan, W. M.; Terao, S.; Granger, D. N.; Kelley, R. E.; Zhao, L. R. The role of stem cell factor and granulocyte-colony stimulating factor in brain repair during chronic stroke. J. Cereb. Blood Flow. Metab. 29(4):759-770; 2009.
22. Piscaglia, A. C.; Shupe, T. D.; Oh, S. H.; Gasbarrini, A.; Petersen, B. E. Granulocyte-colony stimulating factor promotes liver repair and induces oval cell migration and proliferation in rats. Gastroenterology 133(2):619-631; 2007.
23. Qizilbash, N. Fibrinogen and cerebrovascular disease. Eur. Heart J. 16(Suppl. A):42-45; discussion 45-46; 1995.
24. Stec, J. J.; Silbershatz, H.; Tofler, G. H.; Matheney, T. H.; Sutherland, P.; Lipinska, I.; Massaro, J. M.; Wilson, P. F.; Muller, J. E.; D'Agostino, R. B., Sr. Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring Population. Circulation 102(14):1634-1638; 2000.
25. Su, Y.; Cui, L.; Piao, C.; Li, B.; Zhao, L. R. The effects of hematopoietic growth factors on neurite outgrowth. PLoS One 8(10):e75562; 2013.
26. van Oijen, M.; Witteman, J. C.; Hofman, A.; Koudstaal, P. J.; Breteler, M. M. Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia. Stroke 36(12):2637-2641; 2005.
27. Wessendorf, T. E.; Thilmann, A. F.; Wang, Y. M.; Schreiber, A.; Konietzko, N.; Teschler, H. Fibrinogen levels and obstructive sleep apnea in ischemic stroke. Am. J. Respir. Crit. Care. Med. 162(6):2039-2042; 2000.
28. Xu, G.; Zhang, H.; Zhang, S.; Fan, X.; Liu, X. Plasma fibrinogen is associated with cognitive decline and risk for dementia in patients with mild cognitive impairment. Int. J. Clin. Pract. 62(7):1070-1075; 2008.
29. Zhao, L. R.; Berra, H. H.; Duan, W. M.; Singhal, S.; Mehta, J.; Apkarian, A. V.; Kessler, J. A. Beneficial effects of hematopoietic growth factor therapy in chronic ischemic stroke in rats. Stroke 38(10):2804-2811; 2007.
30. Zhao, L. R.; Navalitloha, Y.; Singhal, S.; Mehta, J.; Piao, C. S.; Guo, W. P.; Kessler, J. A.; Groothuis, D. R. Hematopoietic growth factors pass through the blood-brain barrier in intact rats. Exp. Neurol. 204(2):569-573; 2007.
31. Zhao, L. R.; Singhal, S.; Duan, W. M.; Mehta, J.; Kessler, J. A. Brain repair by hematopoietic growth factors in a rat model of stroke. Stroke 38(9):2584-2591; 2007.